Title: US Healthcare Advertising Market Report | Share, Size, Share, Growth, Price Trends And Forecast 2017 - 2022
1 US Healthcare Advertising Market Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2017-2021
Copyright IMARC. All Rights Reserved
2About IMARC Group
Report Description
IMARC is a leading advisor on management
strategy and market research worldwide. We
partner with clients in all sectors and regions
to identify their highest-value opportunities,
address their most critical challenges, and
transform their businesses. IMARCs information
products include major market, scientific,
economic and technological developments for
business leaders in pharmaceutical, industrial,
and high technology organizations. Market
forecasts and industry analysis for
biotechnology, advanced materials,
pharmaceuticals, food and beverage, travel and
tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3Report Description and Highlights
Report Description
Growth of US Healthcare Advertising Market
Driven by Introduction of New Drugs and Digital
Transformation The US healthcare advertising
market witnessed a positive growth owing to
increasing direct-to-consumer (DTC) advertising
and introduction of new drugs in market. As a
result, the market is expected to grow at a CAGR
of 1.5 during 2017-2021. According to IMARC
Groups new report, titled US Healthcare
Advertising Industry Trends, Share, Size,
Growth, Opportunity and Forecast 2017-2021, the
US healthcare advertising market reached a value
of US 407 Billion in 2016, growing at a CAGR of
4 during 2009-2016. With the rising number of
new drugs launched in the market, the need to
advertise these drugs and widen the consumer
reach has also increased. Healthcare advertising
is becoming progressively important in the US so
as to create awareness about various diseases
along with the drugs and procedures required for
their treatments. Owing to its growing need and
increased government support, the US healthcare
advertising market is expected to reach a value
of US 447 Billion by 2021, growing at a CAGR of
1.5 during 2017-2021. Read complete report with
TOC http//www.imarcgroup.com/us-healthcare-adver
tising-market
4Report Description and Highlights
Report Description
5Report Description and Highlights
Report Description
- Highlights of the US healthcare advertising
market - Biopharmaceutical advertising sector represents
the fastest growing segment. - Detailed advertising is the preferred channel of
healthcare advertising. - Major pharmaceutical companies have started
investing in DTC advertising, owing to increased
competition in market. -
- The US healthcare industry is digitally
transforming with the introduction of electronic
health records, telemedicine and remote medical
monitoring system. Also, consumers and healthcare
providers spend most of their time online on
social networking sites. Therefore, digital
advertising is steadily becoming an integral part
of the US healthcare advertising market.
Moreover, increasing presence of generic drugs
has forced pharmaceutical companies to embrace
new business strategies and advertise their
products. The US healthcare advertising market is
further boosted by governments support to
direct-to-consumer (DTC) advertising and
increasing consumer reach through various digital
platforms. - Request for free sample report or more details,
click here http//www.imarcgroup.com/request?type
reportid723flagB
6Report Description and Highlights
Report Description
- Biopharmaceutical advertising market is the
fastest growing segment, followed by
over-the-counter drugs, vaccines and
pharmaceuticals (small molecule drugs). Also,
due to rising consumer demand for helpful and
educational content in the form of blogs, social
media, video and e-mails, the use of DTC channel
is growing rapidly, but detailed advertising is
still preferred over DTC advertising. Some of the
major pharmaceutical companies investing in this
sector include Johnson Johnson, Pfizer, Merck
Co, GlaxoSmithKline, Novartis and Ely Lilly. - The report by IMARC Group has examined the US
Healthcare Advertising Market on the basis of -
- Product
- Pharmaceuticals (Small molecule drugs)
- Biopharmaceuticals
- Vaccines
- Over-the-counter drugs
- Key Players
-
7Report Description and Highlights
Report Description
- Johnson Johnson
- Pfizer
- Merck Co.
- GlaxoSmithKline
- Eli Lilly
- Novartis
- Sanofi
- AstraZeneca
- Roche
- Bayer HealthCare
- Bristol- Myers Squibb
- Browse more reports related to technology media
industry http//www.imarcgroup.com/categories/tec
hnology-market-reports
8Report Description and Highlights
Report Description
2017 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
9 Contact Us